Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 564926, 5 pages
http://dx.doi.org/10.1155/2014/564926
Case Report

Clinical Case of Immune Dysregulation, Polyendocrinopaty, Enteropathy, X-Linked (IPEX) Syndrome with Severe Immune Deficiency and Late Onset of Endocrinopathy and Enteropathy

1University Pediatric Hospital, Sofia, Bulgaria
2Medical School, University of Exeter, UK

Received 6 November 2013; Revised 27 April 2014; Accepted 27 April 2014; Published 1 June 2014

Academic Editor: Nima Rezaei

Copyright © 2014 R. Savova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Rioux, P. Goyette, T. J. Vyse et al., “Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 44, pp. 18680–18685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. European Consortium for IDDM Genome Studies, “A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions,” The American Journal of Human Genetics, vol. 69, no. 6, pp. 1301–1313, 2001. View at Publisher · View at Google Scholar
  3. J. A. Todd, N. M. Walker, J. D. Cooper et al., “Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes,” Nature Genetics, vol. 39, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. Barrett, D. G. Clayton, P. Concannon et al., “Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Moore, M. L. Colli, M. Cnop et al., “PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ- induced pancreatic β-cell apoptosis,” Diabetes, vol. 58, no. 6, pp. 1283–1291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. S. Husebye and M. S. Anderson, “Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis,” Immunity, vol. 32, no. 4, pp. 479–487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. D'Hennezel, K. B. Dhuban, T. Torgerson, and C. Piccirillo, “The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome,” Journal of Medical Genetics, vol. 49, no. 5, pp. 291–302, 2012. View at Publisher · View at Google Scholar
  8. T. Kinnunen, N. Chamberlain, H. Morbach et al., “Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells,” Blood, vol. 121, no. 9, pp. 1595–1603, 2013. View at Publisher · View at Google Scholar
  9. S. M. Leonardo, J. A. Josephson, N. L. Hartog, and S. B. Gauld, “Altered B cell development and anergy in the absence of Foxp3,” Journal of Immunology, vol. 185, no. 4, pp. 2147–2156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Rubio-Cabezas, J. A. L. Minton, R. Caswell et al., “Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes,” Diabetes Care, vol. 32, no. 1, pp. 111–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Moraes-Vasconcelos, B. T. Costa-Carvalho, T. R. Torgerson, and H. D. Ochs, “Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED,” Journal of Clinical Immunology, vol. 28, supplement 1, pp. S11–S19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Ozcan, L. D. Notarangelo, and R. S. Geha, “Primary immune deficiencies with aberrant IgE production,” Journal of Allergy and Clinical Immunology, vol. 122, no. 6, pp. 1054–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Jyonouchi and R. W. Steele, “Hyperimmunoglobulinemia E, (Job) Syndrome,” http://emedicine.medscape.com/article/886988-overview.
  14. B. R. Powell, N. R. M. Buist, and P. Stenzel, “An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy,” Journal of Pediatrics, vol. 100, no. 5, pp. 731–737, 1982. View at Google Scholar · View at Scopus
  15. A. O. Shigeoka, P. F. Chance, P. R. Fain, D. F. Barker, L. S. Book, and M. L. Rallison, “Regional localization of a novel X-linked immunodeficiency with autoimmune disease and enteropathies to the Wiskott-Aldrich locus Xp11.2,” Pediatric Research, vol. 33, article 158A, 1993. View at Google Scholar
  16. P. J. Ferguson, S. H. Blanton, F. T. Saulsbury et al., “Manifestations and linkage analysis in X-linked autoimmuniyi-immunodefficciency syndrome,” The American Journal of Medical Genetics, vol. 90, no. 5, pp. 390–397, 2000. View at Publisher · View at Google Scholar
  17. C. L. Bennet, R. Yoshioka, H. Kiosawa, D. F. Barker, and P. R. Fain, “X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3,” The American Journal of Human Genetics, vol. 66, no. 2, pp. 461–468, 2000. View at Publisher · View at Google Scholar
  18. T. R. Torgerson and H. D. Ochs, “Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells,” Journal of Allergy and Clinical Immunology, vol. 120, no. 4, pp. 744–752, 2007. View at Publisher · View at Google Scholar
  19. E. D'Hennezel, M. Ben-Shoshan, H. D. Ochs et al., “FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1710–1713, 2009. View at Google Scholar · View at Scopus
  20. F. de Benedetti, A. Insalaco, A. Diamanti et al., “Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome,” Clinical Gastroenterology and Hepatology, vol. 4, no. 5, pp. 653–659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Hashimura, K. Nozu, H. Kanegane et al., “Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome,” Pediatric Nephrology, vol. 24, no. 6, pp. 1181–1186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. W. Bae, B. E. Kim, J.-H. Choi et al., “A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome,” European Journal of Pediatrics, vol. 170, no. 12, pp. 1611–1615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Gambineri, L. Perroni, L. Passerini et al., “Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity,” Journal of Allergy and Clinical Immunology, vol. 122, no. 6, pp. 1105–1112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Lal and J. S. Bromberg, “Epigenetic mechanisms of regulation of Foxp3 expression,” Blood, vol. 114, no. 18, pp. 3727–3735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Baron, S. Floess, G. Wieczorek et al., “DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells,” European Journal of Immunology, vol. 37, no. 9, pp. 2378–2389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Barzaghi, L. Passerini, E. Gambineri et al., “Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome,” Journal of Autoimmunity, vol. 38, no. 1, pp. 49–58, 2012. View at Publisher · View at Google Scholar · View at Scopus